Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents/pharmacology; Anti-Retroviral Agents/pharmacology; Antiretroviral Therapy, Highly Active; Body Height; CD4 Lymphocyte Count; Democratic Republic of the Congo; Female; HIV Infections/drug therapy; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Weight Gain
Abstract :
[en] BACKGROUND: The benefits of antiretroviral therapy (ART) underpin the recommendations for the early detection of HIV infection and ART initiation. Late initiation (LI) of antiretroviral therapy compromises the benefits of ART both individually and in the community. Indeed, it promotes the transmission of infection and higher HIV-related morbidity and mortality with complicated and costly clinical management. This study aims to analyze the evolutionary trends in the median CD4 count, the median time to initiation of ART, the proportion of patients with advanced HIV disease at the initiation of ART between 2006 and 2017 and their factors. METHODS AND FINDINGS: HIV-positive adults (≥ 16 years old) who initiated ART between January 1, 2006 and December 31, 2017 in 25 HIV care facilities in Kinshasa, the capital of DRC, were eligible. The data were processed anonymously. LI is defined as CD4≤350 cells/μl and/or WHO clinical stage III or IV and advanced HIV disease (AHD), as CD4≤200 cells/μl and/or stage WHO clinic IV. Factors associated with advanced HIV disease at ART initiation were analyzed, irrespective of year of enrollment in HIV care, using logistic regression models. A total of 7278 patients (55% admitted after 2013) with an average age of 40.9 years were included. The majority were composed of women (71%), highly educated women (68%) and married or widowed women (61%). The median CD4 was 213 cells/μl, 76.7% of patients had CD4≤350 cells/μl, 46.1% had CD4≤200 cells/μl, and 59% of patients were at WHO clinical stages 3 or 4. Men had a more advanced clinical stage (p <0.046) and immunosuppression (p<0.0007) than women. Overall, 70% of patients started ART late, and 25% had AHD. Between 2006 and 2017, the median CD4 count increased from 190 cells/μl to 331 cells/μl (p<0.0001), and the proportions of patients with LI and AHD decreased from 76% to 47% (p< 0.0001) and from 18.7% to 8.9% (p<0.0001), respectively. The median time to initiation of ART after screening for HIV infection decreased from 40 to zero months (p<0.0001), and the proportion of time to initiation of ART in the month increased from 39 to 93.3% (p<0.0001) in the same period. The probability of LI of ART was higher in married couples (OR: 1.7; 95% CI: 1.3-2.3) (p<0.0007) and lower in patients with higher education (OR: 0.74; 95% CI: 0.64-0.86) (p<0.0001). CONCLUSION: Despite increasingly rapid treatment, the proportions of LI and AHD remain high. New approaches to early detection, the first condition for early ART and a key to ending the HIV epidemic, such as home and work HIV testing, HIV self-testing and screening at the point of service, must be implemented.
Disciplines :
Immunology & infectious disease
Author, co-author :
Ngongo, Nadine Mayasi
Darcis, Gilles ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses
Nanituna, Hippolyte Situakibanza
Mambimbi, Marcel Mbula
Maes, Nathalie ; Centre Hospitalier Universitaire de Liège - CHU > Service des Informations médico-économiques > Appui à la recherche clinique et biostatistique
Mashi, Murielle Longokolo
Bepouka Izizag, Ben
Moutschen, Michel ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses
Lepira Bompeka, François
Language :
English
Title :
Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
Publication date :
2021
Journal title :
PLoS ONE
eISSN :
1932-6203
Publisher :
Public Library of Science, United States - California
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach (2006 revision). Geneva, WHO 2006. http://www.who.int/hiv/pub/arv/adult/en/.
World Health Organization. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. Geneva, WHO 2009. http://www.who.int/hiv/pub/arv/advice/en/.
World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Recommendations for a Public Health Approach: 2010 revision. Geneva, WHO 2010. http://www.who.int/hiv/pub/arv/adult2010/en/.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a Public Health Approach. 2013 revision. Geneva, WHO 2013. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf?ua=1.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treatment and preventing HIV infection. Recommendations for a public health approach. Geneva, Switzerland: WHO 2015. https://apps.who.int/iris/bitstream/handle/10665/198064/9789241509893_eng.pdf;sequence=1.
World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva, WHO 2015. https://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach—second edition. Geneva: WHO; 2016. [cited 2020 May 31,]. https://www.who.int/hiv/pub/arv/arv-2016/en/, accessed 25 Sept 2019.
World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017 ISBN 978-92-4-155006-2. https://apps.who.int/iris/bitstream/handle/10665/255884/9789241550062-eng.pdf?sequence=1.
Fact sheet 2019—Latest statistics on the state of the AIDS epidemic. https://www.unaids.org/fr/resources/fact-sheet.
Johnson LF, May MT, Dorrington RE, Cornell M, Boulle A, Egger M, et al. Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study. Suthar AB, éditeur. PLOS Med. 12 déc 2017; 14(12):e1002468. https://doi.org/10.1371/journal.pmed.1002468 PMID: 29232366
Makhema MJ, Wirth K, Pretorius Holme M et al. Impact of prevention and treatment interventions on population HIV incidence: primary results of the communityrandomized Ya Tsie Botswana prevention project. AIDS 2018. July 2018. Amsterdam, the Netherlands. Abstract WEAX0105LB.
Blankley S, Gashu T, Ahmad B, kebra Belaye A, Ringtho L, Mesic A, et al. Lessons learned: Retrospective assessment of outcomes and management of patients with advanced HIV disease in a semi-urban polyclinic in Epworth, Zimbabwe. Peters RP, éditeur. PLOS ONE. 10 avr 2019; 14(4):e0214739. https://doi.org/10.1371/journal.pone.0214739 PMID: 30969987
Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, et al. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med. 2013; 10(4):e1001418. https://doi.org/10.1371/journal.pmed.1001418 PMID: 23585736
Mocroft A, Lundgren JD, Sabin ML, d’Arminio Monforte A, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013; 10(9): e1001510. https://doi.org/10.1371/journal.pmed.1001510 PMID: 24137103
Hønge BL, Jespersen S, Aunsborg J, Mendes DV, Medina C, da Silva Té D, et al. High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau—a cohort study from West Africa. Pan Afr Med J. 2016; 25:40. https://doi.org/10.11604/pamj.2016.25.40.8329 PMID: 28154729
May MT, Vehreschild J-J, Trickey A, Obel N, Reiss P, Bonnet F, et al. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study. Clin Infect Dis Off Publ Infect Dis Soc Am. 15 2016; 62(12):1571–7. https://doi.org/10.1093/cid/ciw183 PMID: 27025828
Biset Ayalew M. Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review. AIDS Res Treat. 2017; 2017:1–10. https://doi.org/10.1155/2017/5415298 PMID: 29214077
Gesesew HA, Ward P, Woldemichael K, Mwanri L. Late presentation for HIV care in Southwest Ethiopia in 2003–2015: prevalence, trend, outcomes and risk factors. BMC Infect Dis. 30 2018; 18(1):59. https://doi.org/10.1186/s12879-018-2971-6 PMID: 29378523
Misgina KH, Weldu MG, Gebremariam TH, Weledehaweria NB, Alema HB, Gebregiorgis YS, et al. Predictors of mortality among adult people living with HIV/AIDS on antiretroviral therapy at Suhul Hospital, Tigrai, Northern Ethiopia: a retrospective follow-up study. J Health Popul Nutr. déc 2019; 38(1):37. https://doi.org/10.1186/s41043-019-0194-0 PMID: 31783924
Lilian RR, Rees K, Mabitsi M, McIntyre JA, Struthers HE, Peters RPH. Baseline CD4 and mortality trends in the South African human immunodeficiency virus programme: Analysis of routine data. South Afr J HIV Med. 2019; 20(1):963. https://doi.org/10.4102/sajhivmed.v20i1.963 PMID: 31392037
Silverman RA, John-Stewart GC, Beck IA, Milne R, Kiptinness C, McGrath CJ, et al. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study. Lessells RJ, éditeur. PLOS ONE. 4 oct 2019; 14(10):e0223411. https://doi.org/10.1371/journal.pone.0223411 PMID: 31584992
Angdembe MR, Rai A, Bam K, Pandey SR. Predictors of mortality in adult people living with HIV on antiretroviral therapy in Nepal: A retrospective cohort study, 2004–2013. Maiga AI, éditeur. PLOS ONE. 23 avr 2019; 14(4):e0215776. https://doi.org/10.1371/journal.pone.0215776 PMID: 31013320
Kiragga AN, Mubiru F, Kambugu AD, Kamya MR, Castelnuovo B. A decade of antiretroviral therapy in Uganda: what are the emerging causes of death? BMC Infect Dis. 21 janv 2019; 19(1):77. https://doi.org/10.1186/s12879-019-3724-x PMID: 30665434
Darcis G, Lambert I, Sauvage A-S, Frippiat F, Meuris C, Uurlings F, et al. Factors associated with late presentation for HIV care in a single Belgian reference center: 2006–2017. Sci Rep. déc 2018; 8 (1):8594. https://doi.org/10.1038/s41598-018-26852-0 PMID: 29872068
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. sept 2016; 375(9):830–9. https://doi.org/10.1056/NEJMoa1600693 PMID: 27424812
Deeks SG, Lewin SR, Bekker L-G. The end of HIV: Still a very long way to go, but progress continues. PLoS Med. nov 2017; 14(11):e1002466. https://doi.org/10.1371/journal.pmed.1002466 PMID: 29190733
Luma HN, Jua P, Donfack O-T, Kamdem F, Ngouadjeu E, Mbatchou HB, et al. Late presentation to HIV/AIDS care at the Douala general hospital, Cameroon: its associated factors, and consequences. BMC Infect Dis. déc 2018; 18(1):298. https://doi.org/10.1186/s12879-018-3204-8 PMID: 29970017
Fox MP, Rosen S. Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008–2013. J Acquir Immune Defic Syndr 1999. 1 mai 2015; 69(1):98–108.
Mutimura E, Addison D, Anastos K, Hoover D, Dusingize JC, Karenzie B, et al. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda. AIDS Lond Engl. 2 janv 2015; 29(1):67–76.
Ministère de la Santé publique, République Démocratique du Congo. Plan Stratégique National de la riposte au VIH/SIDA 2018–2021. 2018.
Ministère de la Santé publique, République démocratique du Congo. Programme national de lutte contre le VIH/SIDA. Rapport annuel 2019.
Ngongo NM, Nani-Tuma HS, Mambimbi MM, Mashi ML, Izizag BB, Ndolumingu FK, et al. Decrease in late presentation for HIV care in Kinshasa, DRC, 2006–2020. AIDS Res Ther. 16 juill 2021; 18(1):41. https://doi.org/10.1186/s12981-021-00366-8 PMID: 34271957
Auld AF, Shiraishi RW, Couto A, Mbofana F, Colborn K, Alfredo C, et al. A Decade of Antiretroviral Therapy Scale-up in Mozambique: Evaluation of Outcome Trends and New Models of Service Delivery Among More Than 300,000 Patients Enrolled During 2004–2013. JAIDS J Acquir Immune Defic Syndr. oct 2016; 73(2):e11–22. https://doi.org/10.1097/QAI.0000000000001137 PMID: 27454248
Tymejczyk O, Brazier E, Yiannoutsos C, Wools-Kaloustian K, Althoff K, Crabtree-Ramírez B, et al. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Med. mars 2018; 15(3): e1002534. https://doi.org/10.1371/journal.pmed.1002534 PMID: 29570723
Nash D, Tymejczyk O, Gadisa T, Kulkarni SG, Hoffman S, Yigzaw M, et al. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013. J Int AIDS Soc. janv 2016; 19(1):20637. https://doi.org/10.7448/IAS.19.1.20637 PMID: 27113335
Yendewa GA, Poveda E, Lakoh S, Yendewa SA, Jiba DF, Salgado-Barreira A, et al. High Prevalence of Late-Stage Disease in Newly Diagnosed Human Immunodeficiency Virus Patients in Sierra Leone. Open Forum Infect Dis [Internet]. 1 sept 2018 [cité 3 juill 2020]; 5(9). Disponible sur: https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofy208/5078457. PMID: 30191158
Carmona S, Bor J, Nattey C, Maughan-Brown B, Maskew M, Fox MP, et al. Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa’s National HIV Program: Data From a Nationwide Laboratory Cohort. Clin Infect Dis. 4 mars 2018; 66(suppl_2):S111–7. https://doi.org/10.1093/cid/ciy045 PMID: 29514238
Benzekri NA, Sambou JF, Ndong S, Tamba IT, Faye D, Diallo MB, et al. Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa. BMC Infect Dis. déc 2019; 19(1):261. https://doi.org/10.1186/s12879-019-3826-5 PMID: 30876400
Kujawski SA, Lamb MR, Lahuerta M, McNairy ML, Ahoua L, Abacassamo F, et al. Advanced Human Immunodeficiency Virus Disease at Diagnosis in Mozambique and Swaziland. Open Forum Infect Dis. 2017; 4(3):ofx156. https://doi.org/10.1093/ofid/ofx156 PMID: 28959700
Fomundam HN, Tesfay AR, Mushipe SA, Mosina MB, Boshielo CT, Nyambi HT, et al. Prevalence and predictors of late presentation for HIV care in South Africa. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 27 nov 2017; 107(12):1058–64. https://doi.org/10.7196/SAMJ.2017.v107i12.12358 PMID: 29262956
Assen A, Molla F, Wondimu A, Abrha S, Melkam W, Tadesse E, et al. Late presentation for diagnosis of HIV infection among HIV positive patients in South Tigray Zone, Ethiopia. BMC Public Health. déc 2016; 16(1):558.
Belay GM, Endalamaw A, Ayele AD. Late presentation of HIV positive adults and its predictors to HIV/ AIDS care in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. déc 2019; 19(1):534. https://doi.org/10.1186/s12879-019-4156-3 PMID: 31208360
Tanuma J, Lee KH, Haneuse S, Matsumoto S, Nguyen DT, Nguyen DTH, et al. Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007–2014. Okulicz JF, éditeur. PLOS ONE. 3 mars 2016; 11(3): e0150781. https://doi.org/10.1371/journal.pone.0150781 PMID: 26939050
Anderegg N, Kirk O on behalf of IeDEA-Global Adults and COHERE. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries. 21st International Workshop on HIV and Hepatitis Observational Databases, Lisbon, Portugal, 30 March–1 April 2017. Abstract 12.
Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002–2013: a meta-analysis. Clin Infect Dis Off Publ Infect Dis Soc Am. 1 avr 2015; 60(7):1120–7.
Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, et al. Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial. PLoS Med. mai 2016; 13(5):e1002015. https://doi.org/10.1371/journal.pmed.1002015 PMID: 27163694
Bor J, Ahmed S, Fox MP, Rosen S, Meyer-Rath G, Katz IT, et al. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study. PloS One. 2017; 12(6): e0178249. https://doi.org/10.1371/journal.pone.0178249 PMID: 28617805
Ford N, Migone C, Calmy A, Kerschberger B, Kanters S, Nsanzimana S, et al. Benefits and risks of rapid initiation of antiretroviral therapy. AIDS Lond Engl. 2 janv 2018; 32(1):17–23. https://doi.org/10.1097/QAD.0000000000001671 PMID: 29112073
Govindasamy D, Meghij J, Kebede Negussi E, Clare Baggaley R, Ford N, Kranzer K. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings—a systematic review. J Int AIDS Soc. 2014; 17:19032. https://doi.org/10.7448/IAS.17.1.19032 PMID: 25095831
Fox MP, Rosen S, Geldsetzer P, Bärnighausen T, Negussie E, Beanland R. Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness. J Int AIDS Soc. janv 2016; 19(1):20888. https://doi.org/10.7448/IAS.19.1.20888 PMID: 27507249
Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, et al. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Lancet HIV. nov 2016; 3(11):e539–48. https://doi.org/10.1016/S2352-3018(16) 30090-X PMID: 27658873
Ruzagira E, Baisley K, Kamali A, Biraro S, Grosskurth H, the Working Group on Linkage to HIV Care. Linkage to HIV care after home-based HIV counselling and testing in sub-Saharan Africa: a systematic review. Trop Med Int Health. juill 2017; 22(7):807–21. https://doi.org/10.1111/tmi.12888 PMID: 28449385
Koduah Owusu K, Adu-Gyamfi R, Zamzam A. Strategies To Improve Linkage To HIV Care In Urban Areas Of Sub-Saharan Africa: A Systematic Review. HIVAIDS—Res Palliat Care. déc 2019; Volume 11:321–32. https://doi.org/10.2147/HIV.S216093 PMID: 31819663
Ford N, Doherty M. The Enduring Challenge of Advanced HIV Infection. N Engl J Med. 20 2017; 377 (3):283–4. https://doi.org/10.1056/NEJMe1707598 PMID: 28723319
Chihana ML, Huerga H, Van Cutsem G, Ellman T, Goemaere E, Wanjala S, et al. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi). Glob Health Action. 1 janv 2019; 12(1):1679472. https://doi.org/10.1080/16549716.2019.1679472 PMID: 31679482
Hakim J, Musiime V, Szubert AJ, Mallewa J, Siika A, Agutu C, et al. Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa. N Engl J Med. 20 2017; 377(3):233–45. https://doi.org/10.1056/NEJMoa1615822 PMID: 28723333
Lahuerta M, Wu Y, Hoffman S, Elul B, Kulkarni SG, Remien RH, et al. Advanced HIV Disease at Entry into HIV Care and Initiation of Antiretroviral Therapy During 2006–2011: Findings From Four Sub-Saharan African Countries. Clin Infect Dis. 1 févr 2014; 58(3):432–41. https://doi.org/10.1093/cid/cit724 PMID: 24198226
Hoffman S, Wu Y, Lahuerta M, Kulkarni SG, Nuwagaba-Biribonwoha H, Sadr WE, et al. Advanced disease at enrollment in HIV care in four sub-Saharan African countries: change from 2006 to 2011 and multilevel predictors in 2011. AIDS. oct 2014; 28(16):2429–38. https://doi.org/10.1097/QAD. 0000000000000427 PMID: 25136842
Gelaw YA, Senbete GH, Adane AA, Alene KA. Determinants of late presentation to HIV/AIDS care in Southern Tigray Zone, Northern Ethiopia: an institution based case-control study. AIDS Res Ther. 2015; 12:40. https://doi.org/10.1186/s12981-015-0079-2 PMID: 26633988
Nyika H, Mugurungi O, Shambira G, Gombe NT, Bangure D, Mungati M, et al. Factors associated with late presentation for HIV/AIDS care in Harare City, Zimbabwe, 2015. BMC Public Health. 03 2016; 16:369. https://doi.org/10.1186/s12889-016-3044-7 PMID: 27142869
Sharma M, Barnabas RV, Celum C. Community-based strategies to strengthen men’s engagement in the HIV care cascade in sub-Saharan Africa. PLoS Med. 2017; 14(4):e1002262. https://doi.org/10.1371/journal.pmed.1002262 PMID: 28399122
Sogbanmu OO, Goon DT, Obi LC, Iweriebor BC, Nwodo UN, Ajayi AI, et al. Socio-demographic and clinical determinants of late presentation among patients newly diagnosed with HIV in the Eastern Cape, South Africa: Medicine (Baltimore). févr 2019; 98(8):e14664.
Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo ZoneEthiopia: a case-control study. AIDS Res Ther. 2011; 8(1):8. https://doi.org/10.1186/1742-6405-8-8 PMID: 21356115
Jeong SJ, Italiano C, Chaiwarith R, Ng OT, Vanar S, Jiamsakul A, et al. Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD. AIDS Res Hum Retroviruses. mars 2016; 32(3):255–61. https://doi.org/10.1089/AID.2015.0058 PMID: 26414065
Beyene MB, Beyene HB. Predictors of Late HIV Diagnosis among Adult People Living with HIV/AIDS Who Undertake an Initial CD4 T Cell Evaluation, Northern Ethiopia: A Case-Control Study. Paraskevis D, éditeur. PLOS ONE. 8 oct 2015; 10(10):e0140004. https://doi.org/10.1371/journal.pone.0140004 PMID: 26448332
Drain PK, Losina E, Parker G, Giddy J, Ross D, Katz JN, et al. Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PloS One. 2013; 8(1):e55305. https://doi.org/10.1371/journal.pone.0055305 PMID: 23383147
Ngongo NM, Nani-Tuma HS, Mambimbi MM, Mashi ML, Izizag BB, Maes N, et al. Progressive phasing out of baseline CD4+ cell count testing for people living with HIV in Kinshasa, Democratic Republic of the Congo. AIDS Lond Engl. 1 avr 2021; 35(5):841–3.
Kulkarni S, Hoffman S, Gadisa T, Melaku Z, Fantehun M, Yigzaw M, et al. Identifying Perceived Barriers along the HIV Care Continuum: Findings from Providers, Peer Educators, and Observations of Provider–Patient Interactions in Ethiopia. J Int Assoc Provid AIDS Care JIAPAC. juill 2016; 15(4):291–300. https://doi.org/10.1177/2325957415593635 PMID: 26173944
Gadisa T, Tymejczyk O, Kulkarni SG, Hoffman S, Lahuerta M, Remien RH, et al. Disclosure History Among Persons Initiating Antiretroviral Treatment at Six HIV Clinics in Oromia, Ethiopia, 2012–2013. AIDS Behav. janv 2017; 21(1):70–81. https://doi.org/10.1007/s10461-016-1290-4 PMID: 26781869
Gesesew HA, Tesfay Gebremedhin A, Demissie TD, Kerie MW, Sudhakar M, Mwanri L. Significant association between perceived HIV related stigma and late presentation for HIV/AIDS care in low and middle-income countries: A systematic review and meta-analysis. Paraskevis D, éditeur. PLOS ONE. 30 mars 2017; 12(3):e0173928. https://doi.org/10.1371/journal.pone.0173928 PMID: 28358828
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.